Uncategorized

Inotek Pharmaceuticals Corporation Reports Second Quarter 2017 Financial Results and Operational Highlights

by Business Wire • 2017/08/03 • 0 Comments

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) today reported financial results and operational highlights for the quarter ended June 30, 2017.

Full Story →

← Laminate Medical’s VasQ Fistula Supporting Device Gets FDA Investigational Device Exemption

Ocular Therapeutix™ Appoints Daniel Bollag, Ph.D., as Senior Vice President, Regulatory Affairs, Pharmacovigilance and Quality →

Post navigation